PRA9 COSTS AND BENEFITS ASSOCIATED WITH ADDITION OF SALMETEROL VERSUS MONTELUKAST TO INHALED CORTICOSTEROID THERAPY IN A MEDICAID ASTHMATIC POPULATION

May 1, 2002, 00:00
10.1016/S1098-3015(10)60983-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)60983-7/fulltext
Title : PRA9 COSTS AND BENEFITS ASSOCIATED WITH ADDITION OF SALMETEROL VERSUS MONTELUKAST TO INHALED CORTICOSTEROID THERAPY IN A MEDICAID ASTHMATIC POPULATION
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60983-7&doi=10.1016/S1098-3015(10)60983-7
First page :
Section Title :
Open access? : No
Section Order : 171
Categories :
Tags :
Regions :
ViH Article Tags :